Sitemap |Contact Us | Bookmark
 
Download instructions: Click "Download" button. Once the eMonograph
opens in a new browser window, select print and print to your
local printer. The request form for credit is included in the PDF.
 
     
   
 
 
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease.
To provide important clinical data on issues related to the management of hepatic encephalopathy.
Upon completion of this activity, participants should be better able to:
  • Identify predictors of hepatic encephalopathy (HE) in patients with cirrhosis and determine appropriate prophylactic regimens for such patients
  • Evaluate the use of breath sample analysis to diagnose HE
  • Describe specific bacteria that are related to cognition and inflammation in HE
  • Determine additional problems that may be associated with neuropsychiatric impairment in HE and assess appropriate screening tools to diagnose these conditions
  • Analyze the development of and treatment with portosystemic shunts in HE
 
   
 
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and the Chronic Liver Disease Foundation (CLDF). Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
  
     
   
 
Purdue University College of Pharmacy designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
     
   
 
All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/ provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, the Chronic Liver Disease Foundation staff and Purdue University College of Pharmacy have no relationships to disclose.
  
 
 
 
HEcme.TV is supported by an educational grant from Salix Pharmaceuticals, Inc.
  
 
© Copyright 2009 HEcme.TV. All rights reserved. This site is maintained as an educational resource for US healthcare providers only. Use of this Web site is governed by the HEcme.TV terms of use and privacy statement.